Erin R. Gardner

Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma

Richard Piekarz, Robin Frye, Maria L. Turner et al. · Journal of Clinical Oncology · 2009 · 728 citations · Full text

Immunology, Pathology, Pharmacotherapy +18

Nelfinavir, A Lead HIV Protease Inhibitor, Is a Broad-Spectrum, Anticancer Agent that Induces Endoplasmic Reticulum Stress, Autophagy, and Apoptosis <i>In vitro</i> and <i>In vivo</i>

Joell J. Gills, Jaclyn LoPiccolo, Junji Tsurutani et al. · Clinical Cancer Research · 2007 · 326 citations

Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation

Christina Therapontos, Lynda Erskine, Erin R. Gardner et al. · Proceedings of the National Academy of Sciences · 2009 · 253 citations · Full text

Limb Defects, Developmental Biology, Angiogenesis +15

Randomized Crossover Pharmacokinetic Study of Solvent-Based Paclitaxel and<i>nab</i>-Paclitaxel

Erin R. Gardner, William L. Dahut, Charity D. Scripture et al. · Clinical Cancer Research · 2008 · 216 citations · Full text

A Pharmacodynamic Study of Docetaxel in Combination with the P-glycoprotein Antagonist Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical Cancer

Ronan J. Kelly, Deborah Draper, Clara C. Chen et al. · Clinical Cancer Research · 2010 · 172 citations · Full text